Dr. Richard Kiss is a medical doctor holding a Ph.D. in molecular oncology. His research topic was the mapping of the genetic and epigenetic background of leukemias and lymphomas, during which he gained extensive experience in the application of molecular genetic methods, such as NGS and liquid biopsy, to support the personalized treatment of hematological malignancies. Along with his research activity, he teaches pathology to medical students at Semmelweis University and is a regular lecturer at scientific conferences and patient education events. As the medical director of Medipredict, he works to integrate the results of state-of-the-art medical testing with omic studies. His mission is to help people maximize their health by using cutting-edge technology and evidence-based science to predict disease risk, provide early detection and give actionable insights to maintain optimal health.
Health Monotoring Showcase:
Medipredict is a digital health company providing a comprehensive evaluation of individual health status and a personalized intervention plan. Our health network approach combines information from multiple sources, such as detailed medical examinations, medical imaging, microbiome analysis, metabolomics, genomics and processing medical history.
High-definition medicine in personalized health preservation
Personalized health preservations via holistic health assessment, high-definition screening, and targeted interventions.
The PMWC 2022 Health Monitoring Showcase will provide 15 minute speaking opportunities for selected companies working with the latest technologies in remote patient and care monitoring, providing devices that are smart and integrated with high-touch approaches, sensors, data collection and analytical capabilities translating patient vital signs into useful insights and alert triggers. These companies will share their innovative products to an audience of leading investors, potential clients, and partners. The PMWC 2019 Health Monitoring Showcase will exhibit the latest innovations that lead to products, systems, and services that empower patients with chronic conditions to better understand and self-manage their conditions and provide clinicians with easy, efficient monitoring that enhance patients’ lives and enable the delivery of better outcomes at lower cost.